Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xingxiang Tu'erfeng is a Traditional Chinese Medicine (TCM) derived from the whole plant of *Ainsliaea fragrans* Champ. Developed and manufactured by Jiangxi Yintao Pharmaceutical, it is primarily utilized for its heat-clearing, detoxifying, and anti-inflammatory effects. The drug is indicated for the treatment of acute pharyngitis and tonsillitis, as well as gynecological conditions including damp-heat leucorrhea and chronic cervicitis. Its pharmacological profile is characterized by the presence of flavonoids and phenolic acids, which contribute to its ability to modulate inflammatory responses and provide broad-spectrum antimicrobial activity against common respiratory and gynecological pathogens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xingxiang tu'erfeng.